utahmedicalprod8k03222010.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 
Date of Report (date of earliest event reported): March 22, 2010


Commission File No. 001-12575


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


                   UTAH                      
 
      87-0342734       
(State or other jurisdiction of
  
(I.R.S. Employer
incorporation or organization)
  
Identification No.)


7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices


Registrant's telephone number:  (801) 566-1200

 
 
 
 
 
ITEM 8.01 OTHER EVENTS
 


On March 22, 2010, Utah Medical Products, Inc. issued a press release announcing the conclusion of a FDA Inspection to assess its compliance with the Quality System Regulation.  A copy of the press release is attached hereto as Exhibit 99.1


 
SIGNATURES
 


Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
     
Date:                      3/22/10                     
By:
/s/ Kevin L. Cornwell
   
Kevin L. Cornwell
   
CEO
 

 
EXHIBIT INDEX

Index
Number                              Description

99.1
Press release issued March 22, 2010: Utah Medical Products, Inc. Announces Conclusion of FDA Inspection